Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Impact of obesity on microvascular insulin action and cardiorespiratory fitness in Type 1 Diabetes

Award Number: R01DK141617
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/01/2026
PERIOD OF PERFORMANCE END DATE: 02/28/2031

Group Awards By:

View Award Description

Impact of obesity on microvascular insulin action and cardiorespiratory fitness in Type 1 Diabetes - Project Summary/Abstract The overall relative risk of cardiovascular disease (CVD) remains 3- to 10-fold higher in individuals with type 1 diabetes (T1D), despite intensive glycemic control and traditional CVD risk management. Epidemiologic studies indicate that more than 60% of individuals with T1D are either overweight or obese, which confer significant additional CVD risk. A better understanding of CVD pathophysiology and the development of additional effective interventions are urgently needed, particularly in the context of the global obesity epidemic, to reduce CVD-related morbidity and mortality in T1D. In the proposed studies we will test an overarching hypothesis that in T1D, endothelial oxidative stress and microvascular insulin resistance lead to reduced skeletal and cardiac muscle microvascular perfusion and cardiorespiratory fitness (CRF), with obesity exacerbating while exercise training mitigating these abnormalities. Specifically, we will test in individuals with T1D whether skeletal and cardiac muscle microvascular insulin resistance predicts CRF reduction and whether obesity worsens both microvascular insulin resistance and CRF decline (Aims 1 and Aim 2). Additionally, we will investigate whether 14 weeks of high-intensity intermittent exercise training attenuates microvascular insulin resistance and improves CRF in humans with either T1D or obesity, with more pronounced improvements in those with both conditions (Aim 3). We will analyze the interrelationships among microvascular insulin responses, microvascular endothelial cell oxidative stress, cardiac function, muscle function, and vascular function before and after exercise training. Results from the proposed studies should define 1) the critical role of microvascular insulin resistance in CRF reduction in T1D, 2) the impact of obesity on microvascular insulin resistance and CRF in T1D, and 3) the potential underlying mechanisms. These will open new avenues for future mechanistic and therapeutic studies in T1D and obesity research.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $782,459 )
2026	2026	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 EMMET ST N	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	2/17/2026	NEW	$782,459
														Subtotal = $782,459

Grand Total All Awards = $782,459

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Impact of obesity on microvascular insulin action and cardiorespiratory fitness in Type 1 Diabetes

Award Number: R01DK141617

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/01/2026

PERIOD OF PERFORMANCE END DATE: 02/28/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer